SCHEMBL27882001

SCHEMBL27882001

NCc1ccccc1CC(=O)Nc1ccc(-c2ccc3ncc(N4CCN(Cc5cccnc5)CC4)nc3c2)cc1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DRD2 P14416 3/20 0.44
▸ HTR1A P08908 2/20 0.44
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43
▸ MAPT P10636 2/20 0.42
▸ MAPK1 P28482 1/20 0.42
▸ SMN1; SMN2 Q16637 1/20 0.42
▸ HCRTR2 O43614 2/20 0.41
▸ KDM4E B2RXH2 3/20 0.41
▸ ALDH1A1 P00352 2/20 0.41
▸ HPGD P15428 1/20 0.41
▸ HIF1A Q16665 2/20 0.40
▸ EPAS1 Q99814 2/20 0.40
▸ FAAH O00519 1/20 0.40
▸ RORC P51449 1/20 0.40
▸ BCHE P06276 1/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ CASP4 P49662 1/20 0.40
▸ CASP5 P51878 1/20 0.40
▸ DRD4 P21917 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1443055 0.91 DRD2 (0.44) DRD2HTR1ANPC1RAB9AMAPT
SCHEMBL13276224 0.91 BCHE (0.51) DRD2HTR1ANPC1RAB9AMAPT
SCHEMBL12812051 0.91 MAPT (0.46) DRD2HTR1ANPC1RAB9AMAPT
SCHEMBL27865624 0.91 HTR1A (0.47) DRD2HTR1ANPC1RAB9AMAPT
SCHEMBL1442810 0.91 HTR1A (0.51) DRD2HTR1ANPC1RAB9AMAPT
SCHEMBL1443280 0.91 DRD2 (0.51) DRD2HTR1ANPC1RAB9AMAPT
SCHEMBL27865644 0.90 HTR1A (0.44) DRD2HTR1ANPC1RAB9AMAPT
SCHEMBL10179675 0.89 HTR1A (0.52) DRD2HTR1ANPC1RAB9AMAPT
SCHEMBL10179010 0.89 MKNK2 (0.46) DRD2HTR1ANPC1RAB9AMAPT
SCHEMBL13276526 0.89 MAPT (0.55) DRD2HTR1AMAPTMAPK1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102596932-A Substituted aminoquinoxalines as tyrosine threonine kinase inhibitors BAYER SCHERING PHARMA AG 2012-07-18 — — CN claimed
Send feedback